Home Categories Biochemical Engineering Ginsenoside Rg2
A4616812

Ginsenoside Rg2 , Analysis of standards,> 98% , 52286-74-5

Synonym(s):
(3β,6α,12β)-3,12,20-Trihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside;Chikusetsusaponin I;Panaxoside Rg2;Prosapogenin C2

CAS NO.:52286-74-5

Empirical Formula: C42H72O13

Molecular Weight: 785.03

MDL number: MFCD00210511

Pack Size Price Stock Quantity
20MG RMB288.80 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 187~189℃
Boiling point: 881.0±65.0 °C(Predicted)
Density  1.30±0.1 g/cm3(Predicted)
storage temp.  2-8°C
solubility  Methanol (Slightly, Heated, Sonicated), Pyridine (Slightly, Sonicated)
pka 12.85±0.70(Predicted)
form  Solid
color  White to Off-White
Stability: Hygroscopic
InChIKey AGBCLJAHARWNLA-DJZXLMSJSA-N
LogP 6.830 (est)

Description and Uses

Ginsenosides are pharmacologically active natural compounds from ginseng and other plants of the genus Panax. Structurally, they are steroid glycosides derived from the triterpene squalene. Ginsenoside Rg2 is a protopanaxatriol that is more abundant in some Panax species (e.g., white and red P. ginseng) than others. This ginsenoside and its metabolites have diverse in vitro and in vivo effects, including neuroprotective, anti-inflammatory, and anti-diabetic actions. It also protects against DNA damage and apoptosis induced by ultraviolet light. Notably, this ginsenoside is increased by the metabolism of other bioactive ginsenosides during the steaming or heating of plant materials, particularly in P. quinquefolium.

20(S)-Ginsenoside Rg2 is used as an aldose reductase inhibitor and my exert anti-inflammatory and immunomodulatory activity. It exists as a bioactive metabolite of the ginsenoside component of Panax ginseng.

Safety

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302
Precautionary statements  P301+P312+P330
Hazard Codes  Xn
Risk Statements  22
Safety Statements  24/25
WGK Germany  3
RTECS  LZ6430000
HS Code  29389090
Toxicity mouse,LD50,intraperitoneal,1340mg/kg (1340mg/kg),Arzneimittel-Forschung. Drug Research. Vol. 25, Pg. 343, 1975.

RELATED PRODUCTS